216 filings
Page 5 of 11
8-K
0obsj
16 Apr 18
Nephros Announces Preliminary Financial Results for First Quarter 2018
12:00am
8-K/A
o18i9i3nv3xp5
11 Apr 18
Entry into a Material Definitive Agreement
12:00am
8-K
f0fwwog4or8ostbsfrjh
11 Apr 18
Nephros Announces $2.9 Million Private Placement
12:00am
8-K
0kpufbkqmi6
30 Mar 18
Entry into a Material Definitive Agreement
12:00am
8-K
3gp5xx7u7iw7ssudnd3
26 Feb 18
Nephros Reports 2017 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
12:00am
8-K
6mpl3y25twjmx0
4 Jan 18
Nephros Announces Preliminary Financial Results for Fourth Quarter 2017
12:00am
8-K
ya90y36 d1x8xks2b
16 Oct 17
Nephros Provides Corporate Update and Announces Preliminary Third Quarter 2017 Revenue
12:00am
8-K
6v5yzuhhp4
27 Sep 17
Entry into a Material Definitive Agreement
12:00am
8-K
xc9z 9a5syv
23 Aug 17
Entry into a Material Definitive Agreement
12:00am
8-K
sl6ke1xh35mrjw3b8ykb
11 Jul 17
Nephros Provides Corporate Update and Second Quarter 2017 Revenue Guidance
12:00am
8-K
gtzce6r4l uphafss0
2 May 17
Departure of Directors or Certain Officers
12:00am
8-K
2db02em2v7bx0f3
23 Mar 17
Nephros Announces $1.2Million Private Placement
12:00am
8-K
mjw5ojyqu9g
14 Feb 17
Nephros Announces Appointment of Andrew Astor as Chief Financial Officer
12:00am
8-K
wwl ayjwmvktr8ac9
24 Jan 17
Nephros Provides Corporate Update and Fourth Quarter 2016 Revenue Guidance
12:00am
8-K
26yj 2bps2u7r9h5tyim
18 Aug 16
Other Events
12:00am
8-K
wntkpr7
7 Jul 16
Departure of Directors or Certain Officers
12:00am
8-K
ire25lql2ge7d0oz4l
14 Jun 16
Entry into a Material Definitive Agreement
12:00am
8-K
6mlrlr9tjlcizf81r
7 Jun 16
Entry into a Material Definitive Agreement
12:00am
8-K
ytcnik
3 May 16
Other Events
12:00am
8-K
3hvz thly50
14 Apr 16
Nephros Receives FDA 510(k) Clearance of S100 Point of Use Filter
12:00am